Biological products
US7355011B2 · kind B2 · utility
15Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2003 |
| Grant date | Apr 8, 2008 |
| Priority date | — |
| Expiry date | Dec 15, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/686
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.